CXL10 (IFN-γ-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 166, Issue 12, 2001, Pages 7617-7624

  Fife, B T ^a   Kennedy, K J ^a   Paniagua, M C ^a   Lukacs, N W ^a   Kunkel, S L ^a   Luster, A D ^a   Karpus, W J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CD4 ANTIGEN; ENCEPHALITOGENIC PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; PROTEOLIPID PROTEIN; ANTISERUM; CHEMOKINE RECEPTOR; CXC CHEMOKINE IP 10; CXC CHEMOKINE IP-10; CXC CHEMOKINE RECEPTOR 3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; ACUTE DISEASE; ADOPTIVE TRANSFER; ANIMAL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; HOSPITALIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE STRAIN; PATHOLOGY; PHYSIOLOGY; SPINAL CORD; TRANSPLANTATION;

ACUTE DISEASE; ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES, CXC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNE SERA; IMMUNOLOGIC MEMORY; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; RECEPTORS, CHEMOKINE; SEVERITY OF ILLNESS INDEX; SPINAL CORD;

EID: 0035874640     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.12.7617     Document Type: Article

References (46)

1. Immunopathogenesis of multiple sclerosis
2. Myelin proteolipid protein: Minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice
3. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis
4. Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis
5. 1 integrin
6. 4 integrin by CD4 T cells is required for their entry into brain parenchyma
7. Antibodies against leukocyte function-associated antigen-1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis
8. Partial inhibition of AT-EAE by an antibody to ICAM-1: Clinico-histological and MRI studies
9. The biology of chemokines and their receptors
10. The role of chemokine receptors in primary, effector, and memory immune responses
11. International union of pharmacology. XXII Nomenclature for chemokine receptors
12. Chemokines: A new classification system and their role in immunity
13. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein: Fine specificity and T cell receptor Vβ usage
14. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis
15. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis
16. Chemokine expression in murine experimental allergic encephalomyelitis
17. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
18. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1
19. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
20. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2
21. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent
22. Lymphocyte-specific chemokine receptor CXCR3: Regulation, chemokine binding and gene localization
23. Interferon-inducible T cell α chemoattractant (1-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
24. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors
25. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
26. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling
27. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
28. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
29. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
30. Homing of T cells to the central nervous system throughout the course of relapsing experimental autoimmune encephalomyelitis in Thy-1 congenic mice
31. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases
32. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis
33. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection
34. + T cells compared
35. Chemokine regulation of experimental autoimmune encephalomyelitis: Temporal and spatial expression patterns govern disease pathogenesis
36. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis
37. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis
38. T-lymphocyte entry into the central nervous system
39. 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis
40. Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of Lewis rat
41. Chemokine expression in GKO mice (lacking interferon-γ) with experimental autoimmune encephalomyelitis
42. IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines
43. + T cells and RANTES in virus-induced central nervous system inflammation and demyelination
44. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model
45. Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1α attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis
46. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease